期刊文献+

B-myb C-myc在肝细胞性肝癌中的表达及临床意义 被引量:16

Expression of B-myb and C-myc in Hepatocellular Carcinoma and Its Clinical Significance
下载PDF
导出
摘要 目的:检测肝细胞性肝癌(hepatocellular carcinoma,HCC)中B-myb及C-myc蛋白的表达情况,探讨其在肝癌发生、发展及转移中的作用。方法:采用免疫组化法检测60例肝癌组织及60例癌旁肝组织中B-myb和C-myc的表达情况。结果:B-myb、C-myc在癌组织中的阳性率分别为56.67%和53.33%,而在癌旁组织中的阳性率分别为36.67%和35.00%,癌组织与癌旁组织比较差异有显著性(P<0.05)。B-myb在肝癌组织中的表达与临床分期、肝外转移、术后复发肿瘤个数及包膜完整相关(P均<0.05);C-myc在肝癌组织中的表达与门静脉癌栓、肝外转移、术后复发、肿瘤分化程度及包膜完整相关(P均<0.05)。B-myb与C-myc在癌组织中的表达正相关。结论:B-myb及C-myc蛋白的过表达,可促使肝癌细胞增殖,使肝癌细胞具有更强的侵袭力,与肝癌的发生、发展密切相关。 Objective: To detect the expression of B-myb and C-myc in hepatoeellular carcinnma(HCC) tissues and to explore its significance in the occurrence, progression and metastasis of HCC. Methods: Immunohistochemisty was employed to detect the expression of B-myb and C-myc in 60 samples of HCC tissues and their adjacent liver tissues. Resuits: The positive rates of B-myb anti C-myc in the HCC tissues were higher than in the adjacent liver tissues (56.67% and 53.33% vs. 36.67% and 35%, P〈0.05). The expression of B-myb in the HCC tissues was significantly eorrelated with the clinical stage, the presence of extrahepatic metastasis, the recurrence of tumor, the number of tumors, and capsule of tumor. The expression of C-myc in the HCC tissues was significantly correlated with portal vein tumor thrombus, the presence of extrahepatic metastasis, the recurrence of tumor, the differentiation and capsule of tumor. The expression of B- myb was positively correlated with the expression of C-myc in HCC tissues. Conclusion: The over-expression of B-myb and C-myc proteins may contribute to the proliferation of hepatocellular carcinoma cells and is related to the occurrence and progression of HCC.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2008年第5期269-271,276,共4页 Chinese Journal of Clinical Oncology
基金 广西壮族自治区青年科学基金资助(编号:桂科青0447050)
关键词 肝细胞性肝癌 B-MYB C-MYC 免疫组织化学 Hepatocellular carcinoma (HCC) B-myb C-mye hnmunohistochemisty
  • 相关文献

参考文献11

  • 1Saville MK, Watson RJ. B-Myb: a key regulator of the cell cycle [J]. Adv Cancer Res, 1998, 72:109-140
  • 2Jonas JC, Laybutt DR, Steil GM, et al. High glucose stimulates early response gene c-Myc expression in rat pancreatic beta cells [J]. J Biol Chem, 2001, 276(38): 35375-35381
  • 3Fu M, Wang C, Li Z, et al. Minireview: Cyclin D1: normal and abnormal functions[J]. Endocrinology, 2004, 145(12): 5439-5447
  • 4Fields WR, Desiderio JG, Putnam KP, et al. Quantification of changes in c-myc mRNA levels in normal human bronchial epithelial (NHBE) and lung adenocarcinoma (A549)cells following chemical treatment [J]. Toxicol Sci, 2001, 63(1): 107-114
  • 5朱波,欧超,罗元,曹骥,班克臣,焦杨,李瑗,苏建家.CyclinD1 c-myc和p53的表达与肝细胞癌生物学行为关系[J].中国肿瘤临床,2006,33(2):67-70. 被引量:12
  • 6Cheng J, Luo J, Zhang X, et al. Inhibition of cell proliferation in HCC-0204 hepatoma cells by a c-myc specific fibozyme [J]. Cancer Gale Ther, 2000, 7(8): 407-412
  • 7Joaquin M, Watson RJ. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57^KIP2 by interacting with its cyclin-binding domain [J]. J Biol Chem, 2003, 278(45): 44255-44264
  • 8Raschella G, Cesi V, Amendola R, et al. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplificadon [J]. Cancer Res, 1999, 59 (14): 3365- 3368
  • 9Sala A. B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer[]]. Eur J Cancer, 2005, 41(16): 2479- 2484
  • 10Hermeking H. The MYC oncogene as a cancer drug target [J]. Curr Cancer Drug Targets, 2003, 3 (3): 163 - 175

二级参考文献2

共引文献11

同被引文献128

引证文献16

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部